These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6326708)

  • 1. Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine.
    Barteling SJ; Woortmeyer R
    Arch Virol; 1984; 80(2-3):103-17. PubMed ID: 6326708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditions for proper formaldehyde inactivation of foot and mouse disease alhydrogel vaccines.
    Barteling SJ
    Dev Biol Stand; 1985; 60():323-9. PubMed ID: 2995172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
    Barteling SJ; Cassim NI
    Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging settled opinions in classic foot-and-mouth disease vaccine preparation.
    Barteling SJ; Anemaet DA
    Dev Biol Stand; 1987; 66():531-8. PubMed ID: 3034709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines.
    Twomey T; Newman J; Burrage T; Piatti P; Lubroth J; Brown F
    Vaccine; 1995 Nov; 13(16):1603-10. PubMed ID: 8578849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innocuity testing of foot-and-mouth disease vaccines. I. Formaldehyde-inactivated alhydrogel vaccines.
    Barteling SJ; Woortmeyer R; Visser N
    J Biol Stand; 1983 Oct; 11(4):297-304. PubMed ID: 6315736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification, characterisation and safety testing of foot-and-mouth disease virus antigens eluted from alhydrogel vaccines.
    Visser N; Woortmeyer R
    Dev Biol Stand; 1981; 50():277-83. PubMed ID: 6176487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by aziridines.
    Burrage T; Kramer E; Brown F
    Vaccine; 2000 May; 18(22):2454-61. PubMed ID: 10738103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic quality of foot-and-mouth disease virus.
    Strobbe R
    Dev Biol Stand; 1976; 35():311-21. PubMed ID: 198301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological studies with cell cultured aluminium hydroxide gel adsorbed formalin inactivated foot and mouth disease type Asia I monovalent vaccine.
    Negi BS; Kumar S
    Indian Vet J; 1970 Jul; 47(7):555-61. PubMed ID: 4318813
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of different inactivation methods on the stability of Indian vaccine strains of foot and mouth disease virus.
    Sarkar A; Tamil Selvan RP; Kishore S; Ganesh K; Bhanuprakash V
    Biologicals; 2017 Jul; 48():10-23. PubMed ID: 28645721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of amino acids in the formaldehyde inactivation of the foot-and-mouth disease virus].
    Ulupov NA
    Veterinariia; 1974 Sep; (9):38-9. PubMed ID: 4377336
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of foot-and-mouth disease vaccines containing endonuclease-inactivated virions.
    Amadori M; Barei S; Melegari M; Panina GF
    Vaccine; 1987 Sep; 5(3):219-22. PubMed ID: 2823495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Routine physico-chemical testing of concentrated virulent and inactivated foot-and-mouth disease virus antigens].
    Adamowicz P; Guerche J; Galampoix J; Prunet P
    Dev Biol Stand; 1976; 35():301-10. PubMed ID: 198300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of foot-and-mouth disease virus vaccine strains by activation of virus-associated endonuclease.
    Scodeller EA; Lebendiker MA; Dubra MS; Crespo OA; Basarab O; La Torre JL; Vasquez C
    J Gen Virol; 1984 Sep; 65 ( Pt 9)():1567-73. PubMed ID: 6088682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of methyl glyoxal on infectivity and antigenicity of foot-and-mouth disease virus.
    Ghizatullina NK
    Acta Virol; 1976 Oct; 20(5):380-6. PubMed ID: 11665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of virus-infection-associated (VIA) antigen of foot-and-mouth disease (FMD) virus from inactivated vaccine.
    Sugimura T; Tsuda T; Suzuki T; Murakami Y
    J Vet Med Sci; 1996 Jun; 58(6):599-601. PubMed ID: 8811637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production.
    Bahnemann HG
    Arch Virol; 1975; 47(1):47-56. PubMed ID: 167679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innocuity testing of foot-and-mouth disease vaccines. II. Aziridine-inactivated antigen produced in baby hamster kidney cells.
    Barteling SJ
    J Biol Stand; 1983 Oct; 11(4):305-12. PubMed ID: 6315737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.